Primary Care Physician
If you notice changes in friend or loved one’s memory,
thinking, or behavior, you should contact their primary care physician. He or
she can help with the following:
- conduct an exam to see if any physical or mental
issue has caused the problems
- give a brief memory-screening test, such as the
Abbreviated Mental Test Score (AMTS). A score lower than six out of ten suggests
a need for further evaluation
- provide essential medical history information
needed for an accurate diagnosis
- identify changes in the patient’s memory and
thinking other may miss.
The doctor also can refer you to the right kind of
specialists as needed. These include:
Geriatricians work with older adults. They know whether
symptoms indicate a serious problem.
Geriatric psychiatrists specialize in mental and emotional
problems of older adults. They can assess memory and thinking problems.
Neurologists focus on abnormalities of the brain and central nervous system. They can conduct and review brain scans.
Neuropsychologists issue tests of memory and thinking.
Memory Clinics & Centers
Places like the Alzheimer’s Disease Research Centers have
teams of specialists to help with diagnosis. For example, a geriatrician can
review your general health; a neuropsychologist can test your thinking and
memory; and a neurologist can use scanning technology to “see” inside your
brain. Tests often are done on site, which speeds up diagnosis.
Getting a Second Opinion
AD diagnosis is not always easy. A second opinion is
sometimes part of the process. Most medical professionals understand this and
should give you a referral. If not, there are a number of other resources
available, including the Alzheimer’s Disease Education and Referral (ADEAR)
Center, which is a service of the National Institute on Aging (NIA).
A Word About Clinical Trials
Although not right for everyone, clinical trials may be an
option. Begin your research at a credible place, such as the Alzheimer's Disease Clinical Trials Database.
This is a joint project of
the NIA and the US Food and Drug Administration (FDA). It is maintained by the
NIA's Alzheimer's Disease Education and Referral (ADEAR) Center.
- Albert, M. S., Dekosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging and Alzheimer's Association workgroup. Alzheimers Dement.
- Alzheimer's Association. (2011). Press Release: New Criteria and Guidelines for the Diagnosis of Alzheimer's Disease Published for the first Time in 27 Years. The Alzheimer's Association, 1-11.
- Arvanitakis, Z., Wilson, R. S., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004). Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol, 61(5), 661-666.
- Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011). Alzheimer's disease. Lancet, 377(9770), 1019-1031.
- Bird, T. D. (2010). Early-Onset Familial Alzheimer Disease. University of Washington, Gene Review.
- Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev(1), CD003120.
- Bosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011). Possible implications of Insulin Resistance and Glucose metabolism in Alzheimer's disease pathogenesis. J Cell Mol Med.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., & Bennett, D. A. (2010). Effect of a purpose in life on risk of incident Alzheimer disease and mild cognitive impairment in community-dwelling older persons. Arch Gen Psychiatry, 67(3), 304-310.
- Boyle, P. A., Buchman, A. S., Barnes, L. L., James, B. D., & Bennett, D. A. (2010). Association between life space and risk of mortality in advanced age. J Am Geriatr Soc, 58(10), 1925-1930.
- Brinkley, T. E., Lovato, J. F., Arnold, A. M., Furberg, C. D., Kuller, L. H., Burke, G. L., et al. (2010). Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women. Am J Hypertens, 23(5), 528-533.
- Daviglus, M. L., Bell, C. C., Berrettini, W., Bowen, P. E., Connolly, E. S., Cox, N. J., et al. (2010). NIH State-of-the-Science Conference Statement: Preventing Alzheimer's Disease and Cognitive Decline. NIH Consens State Sci Statements, 27(4).
- De Felice, F. G., Vieira, M. N., Bomfim, T. R., Decker, H., Velasco, P. T., Lambert, M. P., et al. (2009). Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers. Proc Natl Acad Sci U S A, 106(6), 1971-1976.
- deIpolyi, A. R., Rankin, K. P., Mucke, L., Miller, B. L., & Gorno-Tempini, M. L. (2007). Spatial cognition and the human navigation network in AD and MCI. Neurology, 69(10), 986-997.
- DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., Kronmal, R. A., Ives, D. G., Saxton, J. A., et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262.
- Fillit, H. M., Butler, R. N., O'Connell, A. W., Albert, M. S., Birren, J. E., Cotman, C. W., et al. (2002). Achieving and maintaining cognitive vitality with aging. Mayo Clin Proc, 77(7), 681-696.
- Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., et al. (2009). Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet, 41(10), 1088-1093.
- Herrmann, W., & Obeid, R. (2011). Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med, 49(3), 435-441.
- Keating, D. J., Chen, C., & Pritchard, M. A. (2006). Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res Rev, 5(4), 388-401.
- Ladika, D. J., & Gurevitz, S. L. (2011). Identifying the most common causes of reversible dementias: a review. JAAPA, 24(3), 28-31, 57.
- Li, K., Dai, D., Zhao, B., Yao, L., Yao, S., Wang, B., et al. (2010). Association between the RAGE G82S polymorphism and Alzheimer's disease. J Neural Transm, 117(1), 97-104.
- McKhanna, G. M., Knopmanc, D. S., Chertkowd, H., Hyman, B. T., Clifford R. Jack, J., Kawash, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup.Alzheimer’s & Dementia, 1–7.
- Nation, D. A., Hong, S., Jak, A. J., Delano-Wood, L., Mills, P. J., Bondi, M. W., et al. (2011). Stress, exercise, and Alzheimer's disease: A neurovascular pathway. Med Hypotheses.
- National Library of Medicine. (2011). Alzheimer's Disease. Medline Plus; U.S. National Library of Medicine; National Institutes of Health.
- NCCAM. (2011). National Center for Complementary and Alternative Medicine: The Ginkgo Evaluation of Memory (GEM) Study. National Institutes of Health' National Center for Complementary and Alternative Medicine.
- NIA. (2008). Alzheimer's Disease: Unraveling the Mystery. National Institute on Aging; National Institutes of Heath; US Department of Health and Human Services; NIH Publication Number 08-3782, 1-43.
- NIA. (2011). Caring for a Person with Alzheimer's Disease; Medicine Chart. National Institutes of Health; National Institute on Aging; Alzheimer's Disease Education & Referral Center.
- NINDS. (2010). NINDS Alzheimer's Disease Information Page. National Institute of Neurological Disorders and Stroke; National Institutes of Health; US Department of Health & Human Services.
- NINDS. (2011). Dementia: Hope Through Research. National Institute of Neurological Disorders and Stroke of the National Institutes of Health.
- Panza, F., Frisardi, V., Imbimbo, B. P., D'Onofrio, G., Pietrarossa, G., Seripa, D., et al. (2010). Bapineuzumab: anti-beta-amyloid monoclonal antibodies for the treatment of Alzheimer's disease. Immunotherapy, 2(6), 767-782.
- Redish, A. D. (2001). The hippocampal debate: are we asking the right questions? Behav Brain Res, 127(1-2), 81-98.
- Reitz, C., Brayne, C., & Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nat Rev Neurol, 7(3), 137-152.
- Reitz, C., den Heijer, T., van Duijn, C., Hofman, A., & Breteler, M. M. (2007). Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology, 69(10), 998-1005.
- Seneff, S., Wainwright, G., & Mascitelli, L. (2011). Nutrition and Alzheimer's disease: The detrimental role of a high carbohydrate diet.Eur J Intern Med, 22(2), 134-140.
- Snitz, B. E., O'Meara, E. S., Carlson, M. C., Arnold, A. M., Ives, D. G., Rapp, S. R., et al. (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA, 302(24), 2663-2670.
- Solomon, P. R., Adams, F., Silver, A., Zimmer, J., & DeVeaux, R. (2002). Ginkgo for memory enhancement: a randomized controlled trial. JAMA, 288(7), 835-840.
- Traykov, L., Rigaud, A. S., Cesaro, P., & Boller, F. (2007). [Neuropsychological impairment in the early Alzheimer's disease].Encephale, 33(3 Pt 1), 310-316.
- Uc, E. Y., Rizzo, M., Anderson, S. W., Shi, Q., & Dawson, J. D. (2004). Driver route-following and safety errors in early Alzheimer disease.Neurology, 63(5), 832-837.
- Wegiel, J., Gong, C. X., & Hwang, Y. W. (2011). The role of DYRK1A in neurodegenerative diseases. FEBS J, 278(2), 236-245.
- Wilson, R. S., Mendes De Leon, C. F., Barnes, L. L., Schneider, J. A., Bienias, J. L., Evans, D. A., et al. (2002). Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA, 287(6), 742-748.
- Yu, F. (2011). Guiding Research and Practice: A Conceptual Model for Aerobic Exercise Training in Alzheimer's Disease. Am J Alzheimers Dis Other Demen.